CARLSBAD, Calif.--(BUSINESS WIRE)--GenMark Diagnostics, Inc. (Nasdaq:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced completion of the development stage of its ePlex system, positive preliminary fourth quarter 2014 results, and the closing of a debt facility of up to $40 million led by GE Capital, Healthcare Financial Services.
Help employers find you! Check out all the jobs and post your resume.
